Literature DB >> 2933111

The effect of a calcium antagonist, nitrendipine, on the responses of isolated strips of human, chorionic plate artery to prostaglandins E2 and E1.

F Broughton Pipkin, E Chinnery.   

Abstract

Six point concentration-response curves were established for the contractile effect of prostaglandin E2 (PGE2) on helically-cut strips of human chorionic plate arteries. Tissues were then allocated to one of four treatment groups: a control group and 3 groups exposed to the calcium channel blocker nitrendipine at 10(-9), 10(-7) or 10(-5) M. The concentration-response curves were then repeated. The addition of nitrendipine was associated with a significant depression of the induced contraction. The contractile response to the lower doses of PGE2 was replaced by a small relaxation in 63% of the treated tissues. It is suggested that in these tissues PGE2 exerts its constrictor effect via the receptor-operated channels and that nitrendipine is blocking this effect. Similar experiments performed with PGE1 showed great variability in the initial response. Nitrendipine 10(-5) M failed to exert any detectable effect on this response. Pregnancy-induced hypertension is associated with vasoconstriction in both the maternal and placental circulations. There also appears to be a relative excess of vasoconstrictor eicosanoid production. Nitrendipine may be of use in the treatment of this condition.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2933111      PMCID: PMC1916731          DOI: 10.1111/j.1476-5381.1985.tb08949.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  12 in total

1.  RESPONSES OF NERVE-FREE VESSELS TO VASOACTIVE AMINES AND POLYPEPTIDES.

Authors:  A V SOMLYO; C Y WOO; A P SOMLYO
Journal:  Am J Physiol       Date:  1965-04

2.  Action of adrenaline, acetylcholine and other substances on nerve-free vessels (human placenta).

Authors:  U S V Euler
Journal:  J Physiol       Date:  1938-07-14       Impact factor: 5.182

Review 3.  Mechanisms of action of transmitters and other substances on smooth muscle.

Authors:  T B Bolton
Journal:  Physiol Rev       Date:  1979-07       Impact factor: 37.312

4.  Effects of prostaglandins E1, E2, F1-alpha, F2-alpha on isolated human umbilical and placental blood vessels.

Authors:  K Hillier; S M Karim
Journal:  J Obstet Gynaecol Br Commonw       Date:  1968-06

5.  Drugs and the heart. III. Calcium antagonists.

Authors:  L H Opie
Journal:  Lancet       Date:  1980-04-12       Impact factor: 79.321

6.  Neonatal effects of maternal administration of acebutolol.

Authors:  Y Dumez; C Tchobroutsky; H Hornych; C Amiel-Tison
Journal:  Br Med J (Clin Res Ed)       Date:  1981-10-24

7.  Regional sensitivity to vasoactive polypeptides in the human umbilicoplacental vasculature.

Authors:  T N Tulenko
Journal:  Am J Obstet Gynecol       Date:  1979-11-01       Impact factor: 8.661

8.  Vasoactive actions of prostaglandins and serotonin on isolated human umbilical arteries and veins.

Authors:  M K Park; C Rishor; D C Dyer
Journal:  Can J Physiol Pharmacol       Date:  1972-05       Impact factor: 2.273

9.  The effects of mode of delivery and type of anesthesia on the response of human chorionic plate arteries to prostaglandin E2.

Authors:  A Parkin; F Broughton Pipkin
Journal:  Am J Obstet Gynecol       Date:  1984-07-01       Impact factor: 8.661

10.  Effect of angiotensin II and 5-hydroxytryptamine on the vessels of the human foetal cotyledon.

Authors:  D R Abramovich; K R Page; F Wright
Journal:  Br J Pharmacol       Date:  1983-05       Impact factor: 8.739

View more
  2 in total

1.  Studies on the effects of angiotensin II on human chorionic plate arteries and their modification by a calcium antagonist, nitrendipine.

Authors:  C U Odum; F Broughton Pipkin
Journal:  Br J Clin Pharmacol       Date:  1987-07       Impact factor: 4.335

2.  Some observations on the effects of a calcium channel blocker, nitrendipine, in early human pregnancy.

Authors:  M R Lawrence; F Broughton Pipkin
Journal:  Br J Clin Pharmacol       Date:  1987-06       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.